Although COVID-19 outcomes have improved over the pandemic for patients with RA, some
experience poor acute and postacute outcomes after COVID-19. Clinicians and patients …

Many patients with systemic autoimmune rheumatic diseases (SARDs) require
immunosuppression to reduce disease activity, but this also has important possible …

Objectives To investigate temporal trends in incidence and severity of COVID-19 among
patients with systemic autoimmune rheumatic diseases (SARDs) from the first wave through …

Background Vaccination has been shown to be highly effective in preventing death and
severe disease from severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) …

Clinical data on vaccinated patients with coronavirus disease 2019 (COVID-19) who have
systemic autoimmune and autoinflammatory rheumatic diseases (SAARD) are limited. This …

Objective To analyse the clinical profile of SARS-CoV-2 breakthrough infections in at least
double-vaccinated patients with inflammatory rheumatic diseases (IRDs). Methods Data …

Objectives To identify the effectiveness and safety of inactivated SARS‐CoV‐2 vaccines in
rheumatic and musculoskeletal diseases (RMDs) patients. Methods RMD patients with …

Vaccination remains the most important intervention to attenuate the risk and severity of
infectious diseases in those immunosuppressed for the treatment of rheumatic conditions …

В течение трех лет, прошедших с начала пандемии COVID-19, было выявлено
большое число новых фундаментальных и медицинских проблем, касающихся …

Objectives: To investigate temporal trends in incidence and severity of COVID-19 among
patients with systemic autoimmune rheumatic diseases (SARDs) from the first wave through …